Issue Date | Title | Author(s) |
2021-01-13 | Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine | Yeola, A; Subramanian, S; Oliver, RA; Lucas, CA; Thoms, JAI; Yan, F; Olivier, J; Chacon, D; Tursky, ML; Srivastava, P; Potas, JR; Hung, T; Power, C; Hardy, P; D., D; Kilian, KA; McCarroll, J; Kavallaris, M; Hesson, LB; Beck, D; Curtis, DJ; Wong, JWH; Hardeman, EC; Walsh, WR; Mobbs, R; Chandrakanthan, V; Pimanda, JE |
2016-04-19 | Pdgf-ab and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells | Chandrakanthan, V; Yeola, A; Kwan, JC; Oliver, RA; Qiao, Q; Kang, YC; Zarzour, P; Beck, D; Boelen, L; Unnikrishnan, A; Villanueva, JE; Nunez, AC; Knezevic, K; Palu, C; Nasrallah, R; Carnell, M; Macmillan, A; Whan, R; Yu, Y; Hardy, P; Grey, ST; Gladbach, A; Delerue, F; Ittner, L; Mobbs, R; Walkley, CR; Purton, LE; Ward, RL; Wong, JWH; Hesson, LB; Walsh, W; Pimanda, JE |
2022-11-30 | Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT. | Chappell, LC; Brocklehurst, P; Green, M; Hardy, P; Hunter, R; Beardmore-Gray, A; Bowler, U; Brockbank, A; Chiocchia, V; Cox, A; Duhig, K; Fleminger, J; Gill, C; Greenland, M; Hendy, E; Kennedy, A; Leeson, P; Linsell, L; McCarthy, FP; O'Driscoll, J; Placzek, A; Poston, L; Robson, S; Rushby, P; Sandall, J; Scholtz, L; Seed, PT; Sparkes, J; Stanbury, K; Tohill, S; Thilaganathan, B; Townend, J; Juszczak, E; Marlow, N; Shennan, A |
2019-01-01 | Planned delivery or expectant management for late preterm pre-eclampsia: Study protocol for a randomised controlled trial (PHOENIX trial) | Chappell, LC; Green, M; Marlow, N; Sandall, J; Hunter, R; Robson, S; Bowler, U; Chiocchia, V; Hardy, P; Juszczak, E; Linsell, L; Placzek, A; Brocklehurst, P; Shennan, A |